Return to home page
   Bookmark and Share
 
Return to home page
 
TREATMENT OF UNIOCULAR CHEMICAL INJURY

Amniotic membrane transplantation seems to be useful in the management of severe uniocular chemical burns, according to A. John Kanellopoulos, MD, who described his experience with the procedure.

He is an attending staff surgeon at the Cornea Service, Manhattan Eye, Ear and Throat Hospital, New York, and director of External Diseases, Cornea, and Refractive Surgery at the Ophthalmologic Center of Athens, Greece.

"Amniotic membrane transplantation has been used in limbal stem cell deficiencies, and several investigators have shown dramatic improvement of monocular chemical injury using limbal corneal stem cells from the patient's fellow eye, " noted Dr. Kanellopoulos.

"Because many of these patients have been blind in one eye for years or decades, we attempt to combine autologous limbal stem cell grafting with amniotic membrane transplantation in the surgical management of severe ocular surface disease resulting from uniocular chemical injury," he continued.

All eight patients underwent harvesting of limbal stem cell autografts from the inferior and superiosegments of the fellow healthy eyes. The healthy eyes were anesthetized with topical anesthesia and the injured eye with peribulbar block.

The limbal autografts (two 60° strips) were transplanted onto the damaged eye, followed by transplantation of the amniotic membrane and suturing with 8-0 Vicryl sutures. Re-formation of the superior and inferior fornices is a challenging part of the procedure, according to Dr. Kanellopoulos.

In addition to the transplantation procedure, two patients also underwent penetrating keratoplasty because of dense, deep scarring of the cornea.

"The amniotic membrane not only fosters the transplanted limbal cells but also helps prevent symblepharon formation between the palpebral and bulbar conjunctiva," he said.

Central corneal scarring, superior symblepharon are evident; BCVA is 20/100
Same eye as above 2 months postoperative. Symblepharon is lysed, scarring is reduced; BCVA is 20/25
Significant deep corneal scarring is evident; BCVA is  HM
Same eye as above 7 months postoperative (this procedure included a corneal graft); BCVA is 20/20

Dr. Kanellopoulos reported that there were no perioperative complications associated with the procedure. The improvement in the ocular surface was "dramatic" in all patients. The mean postoperative visual acuity improvement was from 20/400 to 20/100. In one case in which a patient had light perception vision in one eye for 30 years, her best-corrected visual acuity is 20/40 after I year of follow-up.

"This was a small group of patients in whom we achieved good results combining the two treatment modalities," he said."The amniotic membrane may act as a fostering biologic contact lens for the epithelial cells to re-grow and provide comfort for the patient. It also may prevent scar formation by inhibiting the growth of fibroblasts. It also may offer an important mechanical barrier between the eyelid and the newly transplanted epithelium and reduce surface evaporation until the graft and stem cells repopulate significantly.

"In my opinion, fornix reconstruction appears to reduce blepharon recurrence significantly."

Dr. Kanellopoulos does not have a proprietary interest in any aspect of this work.

Source: Ophthalmology Times, Vol. 25, No. 19, October 1, 2000

 

 
 
ISO 9001:2008
Certification

LaserVision.gr
17 Tsocha str., 115 21 Athens
Τel: 210 7472 777 (24/7)
Emergency Τel: 6945 993 598

   
Created by eProductions